Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection

Cytokine-induced killer (CIK) cell therapy has recently been used as an adjuvant setting following resection of hepatocellular carcinoma (HCC), while its benefit remains unclear. This study aimed to evaluate the efficacy of adjuvant CIK application in solitary HCC patients undergoing curative resect...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jian-Lin, Lao, Xiang-Ming, Lin, Xiao-Jun, Xu, Li, Cui, Bo-Kang, Wang, Jun, Lin, Guo-He, Shuang, Ze-Yu, Mao, Yi-Ze, Huang, Xin, Yun, Jing-Ping, Jin, Jie-Tian, Li, Sheng-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748913/
https://www.ncbi.nlm.nih.gov/pubmed/26844496
http://dx.doi.org/10.1097/MD.0000000000002665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748913/
https://www.ncbi.nlm.nih.gov/pubmed/26844496
http://dx.doi.org/10.1097/MD.0000000000002665

Ejemplares similares